Maximus, Inc. (NYSE:MMS)‘s stock had its “sector weight” rating restated by analysts at KeyCorp in a note issued to investors on Thursday, May 25th, MarketBeat.com reports.

Several other equities analysts also recently weighed in on MMS. Zacks Investment Research downgraded shares of Maximus from a “hold” rating to a “sell” rating in a report on Friday, February 10th. Jefferies Group LLC reiterated a “buy” rating and issued a $64.00 price target (down previously from $65.00) on shares of Maximus in a report on Thursday, February 16th. Canaccord Genuity reaffirmed a “buy” rating and set a $62.00 price objective on shares of Maximus in a research note on Friday, April 7th. Maxim Group cut shares of Maximus from a “buy” rating to a “hold” rating and set a $66.00 price objective on the stock. in a research note on Thursday, May 4th. They noted that the move was a valuation call. Finally, ValuEngine cut shares of Maximus from a “buy” rating to a “hold” rating in a research note on Tuesday, May 16th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and one has assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $61.33.

Analyst Recommendations for Maximus (NYSE:MMS)

Maximus (NYSE:MMS) traded down 0.96% on Thursday, reaching $63.76. 663,736 shares of the company’s stock were exchanged. The company has a market cap of $4.13 billion, a PE ratio of 20.90 and a beta of 1.45. Maximus has a 52-week low of $43.69 and a 52-week high of $64.97. The firm’s 50 day moving average price is $62.76 and its 200 day moving average price is $59.31.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, May 4th. The health services provider reported $0.80 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.78 by $0.02. Maximus had a net margin of 8.18% and a return on equity of 26.21%. The company had revenue of $622 million for the quarter, compared to the consensus estimate of $620.24 million. During the same quarter in the prior year, the company earned $0.74 EPS. Maximus’s quarterly revenue was up 2.6% on a year-over-year basis. On average, analysts expect that Maximus will post $3.05 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 31st. Stockholders of record on Monday, May 15th were given a dividend of $0.045 per share. The ex-dividend date was Thursday, May 11th. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.28%. Maximus’s dividend payout ratio (DPR) is 5.86%.

WARNING: “Maximus, Inc. (MMS) Receives “Sector Weight” Rating from KeyCorp” was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another publication, it was illegally copied and republished in violation of U.S. and international trademark & copyright laws. The original version of this news story can be read at https://www.thecerbatgem.com/2017/06/16/maximuss-mms-sector-weight-rating-reiterated-at-keycorp-updated-updated.html.

In other news, CEO Richard A. Montoni sold 30,000 shares of the stock in a transaction that occurred on Thursday, May 25th. The stock was sold at an average price of $62.81, for a total transaction of $1,884,300.00. Following the transaction, the chief executive officer now owns 584,114 shares in the company, valued at approximately $36,688,200.34. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, General Counsel David Francis sold 1,500 shares of the stock in a transaction that occurred on Thursday, April 20th. The shares were sold at an average price of $59.91, for a total value of $89,865.00. Following the transaction, the general counsel now owns 19,716 shares in the company, valued at approximately $1,181,185.56. The disclosure for this sale can be found here. Insiders have sold a total of 112,846 shares of company stock worth $7,073,561 in the last quarter. Insiders own 3.10% of the company’s stock.

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. World Asset Management Inc raised its position in shares of Maximus by 0.8% in the first quarter. World Asset Management Inc now owns 3,976 shares of the health services provider’s stock worth $247,000 after buying an additional 30 shares during the last quarter. Neuburgh Advisers LLC raised its position in shares of Maximus by 1.9% in the first quarter. Neuburgh Advisers LLC now owns 1,696 shares of the health services provider’s stock worth $105,000 after buying an additional 32 shares during the last quarter. Glen Harbor Capital Management LLC raised its position in shares of Maximus by 1.9% in the first quarter. Glen Harbor Capital Management LLC now owns 2,332 shares of the health services provider’s stock worth $145,000 after buying an additional 44 shares during the last quarter. Elkfork Partners LLC raised its position in shares of Maximus by 1.9% in the first quarter. Elkfork Partners LLC now owns 2,968 shares of the health services provider’s stock worth $185,000 after buying an additional 56 shares during the last quarter. Finally, Meadow Creek Investment Management LLC raised its position in shares of Maximus by 1.9% in the first quarter. Meadow Creek Investment Management LLC now owns 3,604 shares of the health services provider’s stock worth $224,000 after buying an additional 68 shares during the last quarter. Institutional investors own 98.67% of the company’s stock.

About Maximus

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Receive News & Stock Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related stocks with our FREE daily email newsletter.